127 filings
Page 6 of 7
8-K
ovxsmcq
9 Mar 12
Anthera Halts VISTA-16 Clinical Study Due to Lack of Efficacy Following Recommendation by the Independent Data Safety Monitoring Board
12:00am
8-K
q3r9 oj11217
6 Mar 12
Anthera Pharmaceuticals Completes Interim Analysis of PEARL-SC Clinical Trial with Blisibimod
12:00am
8-K
tisxeh4vuz8 sfdp585r
6 Mar 12
Dr. Bogdan Dziurzynski Joins Anthera Pharmaceuticals Board of Directors
12:00am
8-K
yrht48n smj
22 Feb 12
Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update
12:00am
8-K
a7m81gq jq2nssm
7 Feb 12
Departure of Directors or Certain Officers
12:00am
8-K
mk9hwoij
2 Dec 11
Anthera Pharmaceuticals Completes Interim B-Cell Analysis of PEARL-SC Study
12:00am
8-K
liwh1hsp
2 Nov 11
Anthera Pharmaceuticals Reports 2011 Thirdquarter Financial
12:00am
8-K
mipnv3
27 Oct 11
Anthera Announces Last Patient Enrolled in PEARL-SC Study
12:00am
8-K
4hgh tad97525
9 Sep 11
Anthera Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application
12:00am
8-K
vp1dz3e pp3rsz66n2pi
9 Aug 11
Entry into a Material Definitive Agreement
12:00am
8-K
hk5390l2 eg75dh5
29 Jul 11
Anthera Pharmaceuticals Reports 2011 Second Quarter Financial Results and Operational Update
12:00am
8-K
o6q7cu
3 Jun 11
Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
12:00am
8-K
4ndjvl5r
3 May 11
Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update
12:00am
8-K
2ieocx2g36xe6h099z
25 Apr 11
Departure of Directors or Certain Officers
12:00am
8-K
3cso89ku ogrjoz
20 Apr 11
Other Events
12:00am
8-K
yalae3e
29 Mar 11
Entry into a Material Definitive Agreement
12:00am
8-K
zertmxmxv
23 Feb 11
Anthera Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results and Operational Update
12:00am
8-K
2yu0 ge6qv0j
1 Feb 11
Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors
12:00am
8-K
1uvxhmtifxzo1a
16 Nov 10
Other Events
12:00am
8-K
0rz 7adkw
2 Nov 10
Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update
12:00am